Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response.
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response.
复制标题
DOI:
10.1016/j.euo.2018.04.019
复制
发表时间:
2018-09
影响因子:
8.2
通讯作者:
Knudsen KE
中科院分区:
文献类型:
--
作者:
Shafi AA;Schiewer MJ;de Leeuw R;Dylgjeri E;McCue PA;Shah N;Gomella LG;Lallas CD;Trabulsi EJ;Centenera MM;Hickey TE;Butler LM;Raj G;Tilley WD;Cukierman E;Knudsen KE
Androgen deprivation therapy is a first-line treatment for disseminated prostate cancer (PCa). However, virtually all tumors become resistant and recur as castration-resistant PCa, which has no durable cure. One major hurdle in the development of more effective therapies is the lack of preclinical models that adequately recapitulate the heterogeneity of PCa, significantly hindering the ability to accurately predict therapeutic response. To leverage the ex vivo culture method termed patient-derived explant (PDE) to examine the impact of PCa therapeutics on a patient-by-patient basis. Fresh PCa tissue from patients who underwent radical prostatectomy was cultured as PDEs to examine therapeutic response. The impact of genomic and chemical perturbations in PDEs was assessed using various parameters (eg, AR levels, Ki67 staining, and desmoplastic indices). PDE maintained the integrity of the native tumor microenvironment (TME), tumor tissue morphology, viability, and endogenous hormone signaling. Tumor cells in this model system exhibited de novo proliferative capacity. Examination of the native TME in the PDE revealed a first-in-field insight into patient-specific desmoplastic stromal indices and predicted responsiveness to AR-directed therapeutics. The PDE model allows for a comprehensive evaluation of individual tumors in their native TME to ultimately develop more effective therapeutic regimens tailored to individuals. Discernment of novel stromal markers may provide a basis for applying precision medicine in treating advanced PCa, which would have a transformative effect on patient outcomes. In this study, an innovative model system was used to more effectively mimic human disease. The patient-derived explant (PDE) system can be used to predict therapeutic response and identify novel targets in advanced disease. Thus, the PDE will be an asset for the development of novel metrics for the implementation of precision medicine in prostate cancer. The patient-derived explant (PDE) model allows for a comprehensive evaluation of individual human tumors in their native tumor microenvironment (TME). TME analysis revealed first-in-field insight into predicted tumor responsiveness to AR-directed therapeutics through evaluation of patient-specific desmoplastic stromal indices.
登录
查看更多内容
DOI:
10.1158/1078-0432.ccr-08-2660
发表时间:
2009-08-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Knudsen KE;Scher HI
通讯作者:
Scher HI
影响因子:
64.5
作者:
Gao D;Vela I;Sboner A;Iaquinta PJ;Karthaus WR;Gopalan A;Dowling C;Wanjala JN;Undvall EA;Arora VK;Wongvipat J;Kossai M;Ramazanoglu S;Barboza LP;Di W;Cao Z;Zhang QF;Sirota I;Ran L;MacDonald TY;Beltran H;Mosquera JM;Touijer KA;Scardino PT;Laudone VP;Curtis KR;Rathkopf DE;Morris MJ;Danila DC;Slovin SF;Solomon SB;Eastham JA;Chi P;Carver B;Rubin MA;Scher HI;Clevers H;Sawyers CL;Chen Y
通讯作者:
Chen Y
影响因子:
14.8
作者:
Drost J;Karthaus WR;Gao D;Driehuis E;Sawyers CL;Chen Y;Clevers H
通讯作者:
Clevers H
影响因子:
14
作者:
Fong EL;Wan X;Yang J;Morgado M;Mikos AG;Harrington DA;Navone NM;Farach-Carson MC
通讯作者:
Farach-Carson MC
影响因子:
7.5
作者:
Alexander, Jennifer;Cukierman, Edna
通讯作者:
Cukierman, Edna